Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours

Breast

Volumn 5, Issue 1, 1996, Pages 13-20

  Podhajcer, O L ^a,c   Wolf, C ^a   Lefebvre, O ^a   Segain, J P ^a   Rouyer, N ^b   Stoll, I ^a   Rio, M C ^a   Chambon, P ^a   Basset, P ^a  

^a l'alimentation et l'Environnement   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; OSTEONECTIN; RNA; SCLEROPROTEIN; STROMELYSIN;

ARTICLE; BREAST ADENOMA; BREAST CARCINOMA; BREAST TUMOR; CELL SUBPOPULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA; TUMOR GROWTH;

EID: 0030028879     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90044-2     Document Type: Article

References (44)

1. Dvorak H F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659.
2. Van den Hoof A. Stromal involvement in malignant growth. Adv Cancer Res 1988; 50: 159-196.
3. Birchmeier C, Birchmeier W. Molecular aspects of mesenchymalepithelial interactions. Ann Rev Cell Biol 1993; 9: 511-540.
4. Zipori D. Stromal cells in tumor growth and regression. Cancer J 1990; 3: 164-169.
5. Blood C H, Zetter B R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
6. Fidler I J. Critical factors in the biology of human cancer metastasis: 28 GHA Clowcs memorial award lecture. Cancer Res 1990; 50: 6130-6138.
7. Stetler-Stevenson W G, Aznavoorian S, Liotta L A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
8. Basset P, Bellocq J P, Wolf C et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699-704.
9. Mason I J, Taylor A, Williams J G, Sage H, Hogan B L M. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial 'culture shock' glycoprotein of Mr 43 000. EMBO J 1986; 5: 1465-1472.
10. Termine J D, Kleinman H K, Whitson S W, Conn K M, McGarvey M L, Martin G R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981; 26: 99-105.
11. Dziadek M, Paulsson M, Aumailley M, Timpl R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur J Biochem 1986; 161: 455-464.
12. Lane T F, Sage E H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994; 8: 163-173.
13. Wewer U M, Albrechtsen R, Fisher L W, Young M F, Termine J D. Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. Am J Pathol 1988; 132: 345-355.
14. Chirgwin J M, Przybyla A E, MacDonald R J, Rutter W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Lefebvre O, Wolf C, Limacher J M et al. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 1992; 119: 997-1002.
17. Wolf C, Rouyer N, Lutz Y et al. Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993; 90: 1843-1847.
18. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucl Acids Res 1982; 10: 1895-7903.
19. Rasmussen U B, Basset P, Daniel J Y. Direct amplification of cDNA inserts from lambda libraries using the cloning adaptor as primer for PCR. Nucl Acids Res 1989; 17: 3308.
20. Swaroop A, Hogan B L M,Francke U. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression and localization of the gene to chromosome 5q31-q33. Genomics 1988; 2: 37-47.
21. Andres A C, van der Valk M A, Schönenberger C A et al. Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev 1988; 2: 1486-1495.
22. Murphy G, Segain J P, O'Shea M et al. The 28 kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J Biol Chem 1993; 268: 15435-15441.
23. Muller D, Wolf C, Abecassis J et al. Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993; 53: 165-169.
24. Rio M C, Bellocq J P, Gairard B et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 1987; 84: 9243-9247.
25. Engel J, Taylor W, Paulsson M, Sage H, Hogan B. Calcium binding domains and calcium-induced conformational transition of SPARC/ BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 1987; 26: 6958-6965.
26. Bolander M E, Young M F, Fisher L W, Yamada Y, Termine J D. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci USA 1988; 85: 2919-2923.
27. Schwarzbauer J, Spencer C S. The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/ osteonectin affects nematode body morphology and mobility. Mol Biol Cell 1993; 4: 941-952.
28. 2+-dependent binding to the extracellular matrix. J Cell Biol 1989; 109: 341-356.
29. Sage E H, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin and thrombospondin. J Biol Chem 1991; 266: 14831-14834.
30. Chiquet-Ehrismann R. Tenascin and other adhesion-modulating proteins in cancer. Cancer Biol 1993; 4: 301-310.
31. Mann K, Deutzmann R, Paulsson M, Timpl R. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett 1987; 218: 167-172.
32. Mayer U, Aumailley M, Mann K, Timpl R, Engel J. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem 1991; 198: 141-150.
33. Lane T F, Iruela-Arispe M L, Sage E H. Regulation of gene expression by SPARC during angiogenesis in vitro: changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 1992; 267: 16736-16745.
34. Raines E W, Lane T F, Iruela-Arispe M L, Ross R, Sage E H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992; 89: 1281-1285.
35. Hasselaar P, Sage E H. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 1992; 49: 272-283.
36. Tremble P M, Lane T F, Sage E H, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodelling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993; 21: 1433-1444.
37. Sappino A P, Skalli O, Jackson B, Schürch W, Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988; 41: 707-712.
38. Ronnov-Jessen L, Van Deurs B, Nielsen M, Petersen O W. Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture. In Vitro Cell Dev Biol 1992; 28A: 273-283.
39. Basset P, Wolf C, Chambon P. Expression of the stromelysin-3 gene in fibroblastic cell of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat 1993; 24: 185-193.
40. Polette M, Clavel C, Cockett M, Girod de Bentzmann S, Murphy G, Birembaut P. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 1993; 13: 31-37.
41. Poulsom R, Hanby A M, Pignatelli M et al. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 1993; 46: 429-436.
42. Ahmed A. The myofibroblast in breast disease. Path Annl 1990; 25: 237-286.
43. Gullick W J. Growth factors and oncogenes in breast cancer. Progress Growth Factor Res 1990; 2: 1-13.
44. Dickson R B, Johnson M D, Bano M et al. Growth factors in breast cancer: mitogenesis to transformation. J Steroid Biochem Molec Biol 1992; 43: 69-78.